Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Hospital admissions linked to hepatitis C on the increase

  • 1 Comment

Hospital admissions from hepatitis C-related end-stage liver disease and liver cancer continue to rise, according to latest figures highlighted by Public Health England.

Although there has been a small drop in deaths in 2013 compared to 2012, PHE said “caution was needed” as overall trends in admissions and deaths had been upwards for more than a decade.

“There is at last real hope that we will begin to see an impact on the number of deaths from hepatitis C-related end-stage liver disease and liver cancer”

Helen Harris

The national public health agency has today published its latest annual report on hepatitis C cases in the UK, noting that while the virus was a “problem” in England, new treatment options and better testing represented a “solution”.

PHE estimates that 160,000 people in England are living with hepatitis C, many of whom are unaware of their infections.

However, it noted that more individuals were being tested and diagnosed for the disease. There have been “particular improvements” seen in primary care, said the report, where surveillance indicates that testing has risen by 21% in England in the last five years.

People who injecting drug users remained at greatest risk of infection, said PHE. The report highlighted the importance of maintaining provision of needle and syringe programmes and opioid substitution therapies in drug services, as part of efforts to prevent the spread of hepatitis C. 

Report author Dr Helen Harris, a hepatitis C expert at PHE, said: “With more patients being tested and improved treatments, there is at last real hope that we will begin to see an impact on the number of deaths from hepatitis C-related end-stage liver disease and liver cancer.

“Antiviral treatments are available in the UK that can successfully clear hepatitis C virus in the majority of patients, and new drugs coming online offer improved rates of viral clearance, fewer side effects, and are easier to administer,” she said.

She highlighted a recent policy announcement making new treatments available to patients with hepatitis C-related cirrhosis.

It  would help to reduce the “future burden” of hepatitis C and a “scale-up” of new treatments in those with less severe disease could achieve a reduction in the numbers of patients who would otherwise go on to develop serious liver disease, she added.

Responding to the PHE report, Charles Gore, chief executive of the Hepatitis C Trust, said: “We are living in a potentially transformative time for hepatitis C. New treatments offer us the chance to save and transform the lives of thousands of people in this country.

“No longer can we tolerate the ever-rising number of people dying from hepatitis C related cirrhosis and liver cancer,” he said. “We can instead create a future where hepatitis C is eliminated as a serious public health concern.”

  • 1 Comment

Readers' comments (1)

  • Now all we need is NHS England to fund all these wonderful new treatments so we can actually use them and cure our patients!!

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.